{"meta":{"query_hash":"a3226bd3ac50","filters":{"venue":"Clinical Medicine Insights Oncology"},"cohort_total":14,"direct_labels_cover":0,"predictions_cover":14,"exported":14,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3226bd3ac50","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Medicine+Insights+Oncology"},"results":[{"id":"W1975700525","doi":"10.4137/cmo.s12811","title":"Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Concordance; Dysplasia; Internal medicine; Predictive value; Polymerase chain reaction; Medicine; Squamous intraepithelial lesion; Gastroenterology; Gynecology; Oncology; Obstetrics; Biology; Cervical intraepithelial neoplasia; Cervical cancer; Cancer; Genetics; Gene","score_opus":0.07016592254959536,"score_gpt":0.3929333716555729,"score_spread":0.32276744910597754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975700525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455853,0.0019254723,0.00017638605,0.050547622,0.0001503268,0.0011783375,0.0000016306261,0.0000059480644,0.0004289892],"genre_scores_gemma":[0.99593997,0.0013528186,0.000035681824,0.0020435043,0.00042766903,0.00014765571,0.000011380907,0.000008546554,0.00003278692],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812925,0.00026669833,0.0009162536,0.00023249272,0.00027067505,0.00018461717],"domain_scores_gemma":[0.9855079,0.013602056,0.00029118473,0.0002904586,0.00021934042,0.00008904191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022241734,0.00010698985,0.00049768476,0.0000734885,0.00017614994,0.0000065737217,0.00017919992,0.00010248667,0.000055799064],"category_scores_gemma":[0.0037455198,0.00004519255,0.00004946192,0.00018181451,0.0011731635,0.000060463324,0.00009305873,0.0006172904,8.278525e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043058065,0.0013249496,0.32817757,0.0018911177,0.00035458748,0.00003507252,0.015817331,0.00002421103,0.015426794,0.002735694,0.007043191,0.62286365],"study_design_scores_gemma":[0.0036118107,0.0025820062,0.96450233,0.00013752164,0.00020793326,0.00008794433,0.0024273845,0.021611936,0.00074357685,0.00027607256,0.0037532663,0.000058216934],"about_ca_topic_score_codex":0.00057561276,"about_ca_topic_score_gemma":0.00017045051,"teacher_disagreement_score":0.63632476,"about_ca_system_score_codex":0.000024034049,"about_ca_system_score_gemma":0.00007180308,"threshold_uncertainty_score":0.44840074},"labels":[],"label_agreement":null},{"id":"W1998810794","doi":"10.4137/cmo.s7658","title":"Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Bladder cancer; Urology; Combination therapy; Internal medicine; Cancer; Oncology","score_opus":0.1626714718544074,"score_gpt":0.4567886025966603,"score_spread":0.29411713074225293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998810794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253094,0.00050160923,0.0005061002,0.0015840641,0.0007077173,0.0017244967,0.000011555547,0.000038429436,0.0023950576],"genre_scores_gemma":[0.9928727,0.0011777814,0.001426221,0.0033443507,0.00045025555,0.0002824294,0.000022114054,0.000044196273,0.00037995516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973558,0.00017945032,0.0013258525,0.0006150778,0.00019224657,0.00033155095],"domain_scores_gemma":[0.9978305,0.00084284303,0.0003014322,0.00037836912,0.0002824223,0.00036439957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038401104,0.00030161111,0.0013561024,0.00025687844,0.000044087967,0.000004385828,0.00019895058,0.0002773619,0.00066486764],"category_scores_gemma":[0.000566018,0.00018752925,0.00011521672,0.00019678666,0.00087615324,0.00012951964,0.00005390843,0.00042732165,0.000004511135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13136002,0.03442682,0.2355123,0.00074646366,0.0020468694,0.0015307408,0.030409874,0.000014495201,0.008134935,0.017590525,0.0027014108,0.53552556],"study_design_scores_gemma":[0.14544645,0.198083,0.6101454,0.0012833559,0.0012263606,0.0003037019,0.0013728056,0.010798427,0.007591217,0.016239922,0.0066232653,0.0008860771],"about_ca_topic_score_codex":0.00045614684,"about_ca_topic_score_gemma":0.00093735504,"teacher_disagreement_score":0.5346395,"about_ca_system_score_codex":0.00012100195,"about_ca_system_score_gemma":0.0007864176,"threshold_uncertainty_score":0.76472205},"labels":[],"label_agreement":null},{"id":"W2013612418","doi":"10.4137/cmo.s4259","title":"Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Island Health","funders":"","keywords":"Imatinib mesylate; GiST; Imatinib; Medicine; PDGFRA; Tyrosine-kinase inhibitor; Oncology; Targeted therapy; Internal medicine; Adverse effect; Tyrosine kinase; Stromal tumor; Cancer research; Stromal cell; Gastroenterology; Receptor; Cancer","score_opus":0.19490410281532752,"score_gpt":0.4203636887698943,"score_spread":0.22545958595456675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013612418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596924,0.0037850295,0.000008826738,0.019321265,0.00014725457,0.00080777495,0.000003116331,0.000027115118,0.016207179],"genre_scores_gemma":[0.9885513,0.006531695,0.0033454613,0.000197122,0.001228179,0.000082982544,0.000014968229,0.000017926584,0.000030369116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729174,0.00050507503,0.001005335,0.00045183054,0.00032804487,0.00041797513],"domain_scores_gemma":[0.99700963,0.0017687347,0.0002780474,0.0004147882,0.00017515628,0.0003536355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006081605,0.0002814966,0.0010913392,0.00018755517,0.000052757645,0.0000032327862,0.00017756973,0.00008938004,0.00022519329],"category_scores_gemma":[0.0005285507,0.00013387791,0.00012153781,0.00019195321,0.0012499817,0.000048066606,0.000037320468,0.0004016518,0.000010450357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071234475,0.017574925,0.682186,0.00038222488,0.0002704327,0.02073942,0.011705869,1.6601021e-7,0.00032130527,0.008280604,0.00038032897,0.25103527],"study_design_scores_gemma":[0.008929279,0.1257141,0.84005266,0.0004313419,0.00020578635,0.0059921164,0.008059638,0.000017532722,0.00010169299,0.0010373149,0.009355196,0.00010337512],"about_ca_topic_score_codex":0.00022767617,"about_ca_topic_score_gemma":0.00033168134,"teacher_disagreement_score":0.25093192,"about_ca_system_score_codex":0.00008521457,"about_ca_system_score_gemma":0.00021151298,"threshold_uncertainty_score":0.54593825},"labels":[],"label_agreement":null},{"id":"W2019669516","doi":"10.4137/cmo.s6460","title":"Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations","year":2012,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Trastuzumab; Metastatic breast cancer; Breast cancer; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.2429678331864455,"score_gpt":0.5547950459468237,"score_spread":0.3118272127603782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019669516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7605424,0.007107382,0.00126294,0.20107277,0.009720377,0.005016505,0.0003204794,0.00017295154,0.0147842085],"genre_scores_gemma":[0.9724276,0.0041415077,0.003043061,0.011489479,0.007945736,0.0004558364,0.000052353484,0.000061707,0.00038273603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953961,0.0009269317,0.002027852,0.0006819435,0.00026004933,0.0007071455],"domain_scores_gemma":[0.9841303,0.013423,0.00034278366,0.00044647287,0.00035310915,0.0013042927],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032351683,0.0003003116,0.0018206295,0.0001777836,0.0001966301,0.000013197838,0.00012964869,0.00042913322,0.0019954448],"category_scores_gemma":[0.0032016134,0.00021412077,0.00024291273,0.00011510147,0.0029977877,0.00015082111,0.00009869793,0.001014953,0.00009799232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042929864,0.005145566,0.36165863,0.00052905746,0.002587123,0.00035035252,0.0030577704,0.0000046422115,0.00029151532,0.03040992,0.29192063,0.2997518],"study_design_scores_gemma":[0.026429325,0.019219197,0.5070374,0.0005586756,0.0023628725,0.0022557266,0.0012819569,0.0010320981,0.00013867,0.0064464896,0.4326529,0.0005846916],"about_ca_topic_score_codex":0.0003861795,"about_ca_topic_score_gemma":0.0005894329,"teacher_disagreement_score":0.2991671,"about_ca_system_score_codex":0.00044312997,"about_ca_system_score_gemma":0.0020659436,"threshold_uncertainty_score":0.9997155},"labels":[],"label_agreement":null},{"id":"W2329997776","doi":"10.4137/cmo.s32813","title":"Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations","year":2016,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Ovarian cancer; Tamoxifen; Medicine; Hormone; Estrogen receptor; Ovarian carcinoma; Hormone receptor; Oncology; Internal medicine; Serous fluid; Cancer; Breast cancer; Estrogen; Gynecology; Bioinformatics; Biology","score_opus":0.1605716960928768,"score_gpt":0.4398224549734831,"score_spread":0.2792507588806063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329997776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053660694,0.98166496,0.0000062333593,0.009657523,0.0017296453,0.003862879,0.0000407564,0.00007222022,0.0024291852],"genre_scores_gemma":[0.0022808162,0.99087596,0.0006047769,0.00093021913,0.0026987963,0.001952319,0.00020925322,0.00010253485,0.00034534134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935806,0.001171782,0.00293273,0.001460185,0.00028407745,0.0005706563],"domain_scores_gemma":[0.99196064,0.0054973303,0.00081990263,0.00078792893,0.00016970333,0.0007645005],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006711126,0.00088810065,0.006455648,0.00054468715,0.00012926804,0.000015122151,0.00011964921,0.0014190483,0.0005059665],"category_scores_gemma":[0.0010025026,0.0004656102,0.0005310193,0.0003757685,0.0011745369,0.000060722286,0.000100288555,0.00063401554,0.00011094546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010554708,0.0021473637,0.0027259118,0.00087929843,0.0007580435,0.002837541,0.00020051179,1.010729e-8,6.5383836e-7,0.0010199624,0.0049593886,0.98436576],"study_design_scores_gemma":[0.011064985,0.013115394,0.005366792,0.008147533,0.0044761887,0.0008053045,0.000042826417,7.95819e-7,8.647966e-7,0.00030027505,0.95628333,0.00039572633],"about_ca_topic_score_codex":0.00020841266,"about_ca_topic_score_gemma":0.00042524392,"teacher_disagreement_score":0.98397005,"about_ca_system_score_codex":0.0015104099,"about_ca_system_score_gemma":0.0027489867,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W2517906931","doi":"10.4137/cmo.s40479","title":"Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study","year":2016,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Cachexia; Breast cancer; Wasting; Metastasis; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Weight loss; Obesity","score_opus":0.1574341368807754,"score_gpt":0.49482055070780095,"score_spread":0.33738641382702556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517906931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96695286,0.0008962108,0.0000213564,0.030180903,0.0005717631,0.00085456134,0.0000033693088,0.000041385963,0.000477591],"genre_scores_gemma":[0.995165,0.0014598483,0.00045036705,0.0018605526,0.0008453168,0.00016127214,5.0987524e-7,0.000019411538,0.000037727063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768734,0.00037702703,0.00095109496,0.00046388464,0.00022131529,0.00029933912],"domain_scores_gemma":[0.9976006,0.0012622315,0.00019950129,0.0002535863,0.00018112973,0.00050296093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063830096,0.00017658644,0.0009394693,0.00023156515,0.000076207805,0.0000028656248,0.000048129023,0.00014486673,0.00014379389],"category_scores_gemma":[0.00028130927,0.00008463018,0.000032626267,0.00025523754,0.0004460943,0.00006225505,0.000050797637,0.0004276357,0.000004856773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011040285,0.0013423602,0.6161485,0.0000677076,0.000084188374,0.03780266,0.002033345,6.3921036e-8,0.0000865172,0.000020580605,0.00017871599,0.34113136],"study_design_scores_gemma":[0.059731923,0.0362495,0.79569435,0.004032661,0.00079732353,0.059234727,0.02269283,0.00003180712,0.00008816767,0.00022250421,0.020829573,0.00039462993],"about_ca_topic_score_codex":0.0012936284,"about_ca_topic_score_gemma":0.0014121971,"teacher_disagreement_score":0.34073672,"about_ca_system_score_codex":0.00023944404,"about_ca_system_score_gemma":0.00029294784,"threshold_uncertainty_score":0.34511185},"labels":[],"label_agreement":null},{"id":"W2593911674","doi":"10.1177/1179554917691266","title":"Understanding Women’s Choice of Mastectomy Versus Breast Conserving Therapy in Early-Stage Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Breast cancer; Mastectomy; Worry; Thematic analysis; Qualitative research; Medicine; Psychology; Cancer; Internal medicine; Sociology","score_opus":0.21984703430698485,"score_gpt":0.44157666264490986,"score_spread":0.221729628337925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593911674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707443,0.0006400444,0.000043003936,0.006400562,0.0016327709,0.0002536226,0.000043022705,0.0000124609,0.0039000977],"genre_scores_gemma":[0.99493587,0.0030296072,0.00003662383,0.0006000794,0.0011592057,0.00010031986,0.0000106326,0.000027213631,0.00010044313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979896,0.00021779774,0.0006824903,0.00054060214,0.0001711349,0.00039839343],"domain_scores_gemma":[0.99785787,0.0005690118,0.0005668412,0.00069352624,0.00014307593,0.00016967044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040623255,0.00025520587,0.00076363643,0.00008630743,0.00019179014,0.000010697847,0.0004640153,0.00034171133,0.00019438958],"category_scores_gemma":[0.0004483233,0.00018846977,0.00009812693,0.00007852343,0.0014680516,0.0000137613315,0.00025628175,0.0002770833,0.0000034879367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074281744,0.0006210229,0.96360976,0.00005209744,0.00073643704,0.00008389069,0.0012486131,0.000008160065,0.0045983596,0.00037518996,0.0007571651,0.020481158],"study_design_scores_gemma":[0.019624965,0.0023090672,0.9631137,0.00015540405,0.000048984766,0.000022072369,0.0011428004,0.0000108455015,0.00038700303,0.000190507,0.012764386,0.00023022096],"about_ca_topic_score_codex":0.0024953536,"about_ca_topic_score_gemma":0.00501142,"teacher_disagreement_score":0.020250937,"about_ca_system_score_codex":0.00034103775,"about_ca_system_score_gemma":0.00029973383,"threshold_uncertainty_score":0.7685574},"labels":[],"label_agreement":null},{"id":"W2601228975","doi":"10.1177/1179554917698461","title":"Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non–Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage?","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Radiation therapy; Nuclear medicine; Medicine; Radiation treatment planning; Lung cancer; Breathing; Volume (thermodynamics); Margin (machine learning); Radiology; Computer science; Physics; Pathology","score_opus":0.015686181959514267,"score_gpt":0.3814454330483923,"score_spread":0.365759251088878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601228975","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092385635,0.0002821717,0.89620954,0.0057015214,0.0024359543,0.0015466365,0.00003539936,0.00009725163,0.0013058758],"genre_scores_gemma":[0.81205773,0.00019624237,0.17958614,0.0019961426,0.0049122516,0.0005662392,0.00009454551,0.00008886751,0.0005018622],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99773186,0.0001556338,0.00076676294,0.00071999413,0.00020157079,0.0004241558],"domain_scores_gemma":[0.9970674,0.0007439119,0.00096451887,0.00067764526,0.0003212258,0.00022530156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049315405,0.00035147349,0.0009464606,0.00011400871,0.0004917045,0.00004027414,0.00046274182,0.00016210043,0.00046745405],"category_scores_gemma":[0.000024037305,0.00019711931,0.00018937905,0.00007345874,0.0007740094,0.0002236698,0.000067525325,0.0005623579,3.6702122e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006071013,0.0011365917,0.8236176,0.00009011695,0.00064459204,0.000039489267,0.00028039564,0.00045246328,0.009827168,0.0010651672,0.0071743582,0.15506496],"study_design_scores_gemma":[0.045395765,0.010455821,0.19133443,0.0007410343,0.000827254,0.000009498572,0.00015923282,0.4951764,0.006595266,0.017710326,0.2296206,0.0019743682],"about_ca_topic_score_codex":0.00029510842,"about_ca_topic_score_gemma":0.000029804027,"teacher_disagreement_score":0.7196721,"about_ca_system_score_codex":0.00016926337,"about_ca_system_score_gemma":0.0003606613,"threshold_uncertainty_score":0.80382925},"labels":[],"label_agreement":null},{"id":"W2807016910","doi":"10.1177/1179554918779581","title":"Precision Medicine in Head and Neck Cancer: Myth or Reality?","year":2018,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Head and neck squamous-cell carcinoma; Head and neck cancer; Precision medicine; Personalized medicine; Clinical trial; Medicine; Cancer; Medical physics; Bioinformatics; Internal medicine; Biology; Pathology","score_opus":0.19754686613586656,"score_gpt":0.5213579928452671,"score_spread":0.3238111267094005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807016910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.739743,0.006046663,0.000041889893,0.17800976,0.003271566,0.00082117406,0.000002804325,0.00009179692,0.07197136],"genre_scores_gemma":[0.9136686,0.034658644,0.00061754556,0.038028352,0.010574253,0.00011224134,0.00001453839,0.000044464556,0.0022814067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961338,0.00039923785,0.0017457367,0.0008202611,0.00040479781,0.00049618393],"domain_scores_gemma":[0.99528545,0.0029676894,0.00028271807,0.0005085745,0.00036232732,0.0005932102],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014734088,0.00031878223,0.002332509,0.00028733286,0.00013620981,0.0000028874492,0.00016542892,0.00049125875,0.0012241482],"category_scores_gemma":[0.0054871184,0.00016913346,0.000065024324,0.00060415996,0.003451335,0.00007764067,0.00015902365,0.0007777307,0.00003773731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011882268,0.0010656203,0.078425914,0.00029343332,0.00021144851,0.0012383002,0.0077359346,1.8527656e-7,0.00084303546,0.0009381179,0.25481188,0.64255387],"study_design_scores_gemma":[0.017658938,0.04241617,0.22281379,0.002448701,0.00021335202,0.00015049634,0.00063937233,0.00011923903,0.00006054847,0.0013847151,0.7119007,0.00019397022],"about_ca_topic_score_codex":0.0018217727,"about_ca_topic_score_gemma":0.0110095935,"teacher_disagreement_score":0.6423599,"about_ca_system_score_codex":0.0002457856,"about_ca_system_score_gemma":0.0006201437,"threshold_uncertainty_score":0.99968886},"labels":[],"label_agreement":null},{"id":"W2914100918","doi":"10.1177/1179554919829500","title":"Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort","year":2019,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer; Cancer Care Ontario; Ontario Stroke Network; Northeast Cancer Centre; NOSM University; Laurentian University; Health Sciences North","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care; Government of Ontario; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Rurality; Palliative care; End-of-life care; Medicine; Rural area; Population; Odds ratio; Family medicine; Gerontology; Nursing; Environmental health","score_opus":0.08054192620698813,"score_gpt":0.4237900307381516,"score_spread":0.34324810453116344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914100918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317837,0.0029912533,0.0000028438378,0.0011116732,0.0003596016,0.0023119047,0.000010099759,0.0000021274582,0.000032129912],"genre_scores_gemma":[0.99706316,0.0014003254,0.000019870757,0.00112967,0.000046245004,0.00028896038,0.00003710419,0.000010973271,0.00000369862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980673,0.00025339672,0.000892635,0.00031898305,0.00027194023,0.00019572358],"domain_scores_gemma":[0.9951763,0.0039670262,0.0003735872,0.00018891827,0.00016153496,0.00013263867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021079881,0.00017514198,0.0010903695,0.00018287974,0.000020031463,0.0000014006396,0.00010692171,0.00016072918,0.000015773967],"category_scores_gemma":[0.0012423233,0.000112475274,0.00005104814,0.00015567648,0.00019339887,0.000029532852,0.000057261608,0.00028502778,5.361488e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010192733,0.000166855,0.9812389,0.00059299567,0.000054998083,0.000007123742,0.010977408,0.00014820346,0.000012164601,0.0000056496915,0.000009575071,0.0057668425],"study_design_scores_gemma":[0.005535585,0.0029329685,0.98308724,0.0052070986,0.00009652366,7.429095e-8,0.0023334743,0.000047814414,0.000049504153,0.000015612703,0.0005938167,0.00010028082],"about_ca_topic_score_codex":0.9304486,"about_ca_topic_score_gemma":0.9978218,"teacher_disagreement_score":0.06737324,"about_ca_system_score_codex":0.0011300304,"about_ca_system_score_gemma":0.0010073561,"threshold_uncertainty_score":0.45866084},"labels":[],"label_agreement":null},{"id":"W3131909373","doi":"10.1177/1179554921993069","title":"The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase","year":2021,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"NIH Clinical Center; National Cancer Institute","keywords":"Oncolytic virus; Myxoma virus; Biology; Soft tissue sarcoma; Gene silencing; Cancer research; Virology; Cell culture; Ribonucleotide reductase; Virus; Sarcoma; Gene; Pathology; Medicine","score_opus":0.044721070711315675,"score_gpt":0.40633089908749215,"score_spread":0.3616098283761765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131909373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018384,0.0048633623,0.000049071023,0.0121174045,0.0004667678,0.00040216514,0.00005643907,0.000009847,0.001851075],"genre_scores_gemma":[0.9900595,0.0056978157,0.000042266314,0.0027172593,0.0006187587,0.0000296296,0.00011094117,0.000034390516,0.00068942783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958391,0.0017193212,0.001038726,0.00055340363,0.00047252016,0.00037690182],"domain_scores_gemma":[0.99467915,0.0028657517,0.00058070966,0.0011747583,0.00047656766,0.00022308234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014973776,0.00023596612,0.00069633644,0.000040492156,0.00019185753,0.000006657328,0.00069553236,0.00046595695,0.0001739879],"category_scores_gemma":[0.004517108,0.00012791307,0.00017970917,0.00029383856,0.0023923172,0.000006151017,0.0003753351,0.0005847762,0.00001279447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028845803,0.000585549,0.000120144956,0.000021206273,0.000178937,0.000026802963,0.00013059139,0.0000027033864,0.88403755,0.000014892075,0.056046337,0.055950698],"study_design_scores_gemma":[0.0021911198,0.007937818,0.00049204956,0.000058718328,0.000044701228,0.0000143817015,0.00014666849,0.00008101197,0.7794067,0.00018969078,0.20932487,0.00011226043],"about_ca_topic_score_codex":0.00006555176,"about_ca_topic_score_gemma":0.00037571118,"teacher_disagreement_score":0.15327853,"about_ca_system_score_codex":0.00004629708,"about_ca_system_score_gemma":0.0009041066,"threshold_uncertainty_score":0.88145924},"labels":[],"label_agreement":null},{"id":"W4210649172","doi":"10.1177/11795549211036898","title":"Radiation-Induced Fibrosis in Patients with Head and Neck Cancer: A Review of Pathogenesis and Clinical Outcomes","year":2022,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Head and neck cancer; Etiology; Radiation therapy; Presentation (obstetrics); Head and neck; Intensive care medicine; Cancer; Pathogenesis; Bioinformatics; Oncology; Internal medicine; Surgery","score_opus":0.1627734475307797,"score_gpt":0.49380680224531975,"score_spread":0.33103335471454004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210649172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022833997,0.9710724,3.10905e-7,0.0021757593,0.0009695597,0.0024203479,0.00003760563,0.000021341659,0.0004686877],"genre_scores_gemma":[0.00020410186,0.99438447,0.000116921685,0.004243022,0.00044141678,0.0003974909,0.00011531954,0.000055500113,0.000041788575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99298435,0.0013359651,0.003908315,0.0009591946,0.00047545967,0.00033668336],"domain_scores_gemma":[0.9900744,0.0073025255,0.001464963,0.0005480521,0.00018460727,0.00042547466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015336156,0.0005438086,0.0105033,0.00029386248,0.000081593185,0.0000022748002,0.0001719826,0.0006009895,0.00030064178],"category_scores_gemma":[0.004437056,0.0003045978,0.0004183552,0.00060957007,0.0009410408,0.00004358154,0.00023276621,0.0012423872,0.0000021732299],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019978777,0.00058039976,0.20266925,0.02941462,0.0005067164,0.000049594983,0.000060782553,2.1851747e-9,1.40604e-8,0.000008471634,0.0007654082,0.7657449],"study_design_scores_gemma":[0.006113275,0.012260446,0.2404122,0.067595,0.0032060617,0.0000106280695,0.000015799966,3.284866e-7,1.36673375e-8,0.0000044160847,0.670179,0.0002028073],"about_ca_topic_score_codex":0.00021629558,"about_ca_topic_score_gemma":0.00021351056,"teacher_disagreement_score":0.76554215,"about_ca_system_score_codex":0.000263714,"about_ca_system_score_gemma":0.0014896132,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W4385476635","doi":"10.1177/11795549231187264","title":"Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Monoclonal antibody; Oncology; Cancer; Chemotherapy; Cytotoxic T cell; Internal medicine; Drug resistance; Antibody; Immunology; Cancer research; Biology; In vitro","score_opus":0.3221679591626192,"score_gpt":0.5417869366401211,"score_spread":0.21961897747750192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051512077,0.9714669,0.0000060138304,0.010853077,0.0046221195,0.002936721,0.00007813714,0.0001890252,0.009796497],"genre_scores_gemma":[0.000060948558,0.98881286,0.00027859732,0.0020271528,0.005194285,0.0011805549,0.00046123532,0.00021782826,0.0017665178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99131674,0.0009913791,0.0045971065,0.0016625766,0.00060310954,0.00082912017],"domain_scores_gemma":[0.9906905,0.0058458336,0.0012859115,0.0011849515,0.00022160764,0.0007711525],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014434243,0.0009907277,0.009890564,0.00091615086,0.00008722658,0.000013544563,0.0004123811,0.0020628318,0.0016354644],"category_scores_gemma":[0.001937984,0.00060887216,0.00080768485,0.0016280055,0.00083521084,0.000053834374,0.00019621338,0.0023747396,0.000596886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032386274,0.001581389,0.00014268969,0.0074382364,0.001280229,0.007816833,0.00014943734,2.8234098e-7,4.2642856e-7,0.00093221915,0.018437585,0.96189684],"study_design_scores_gemma":[0.009946292,0.005300754,0.0013330503,0.04843403,0.0053335503,0.00012710562,0.000041592284,0.000008451903,2.2991311e-7,0.00044705372,0.9285605,0.0004673932],"about_ca_topic_score_codex":0.0011500621,"about_ca_topic_score_gemma":0.0031543276,"teacher_disagreement_score":0.9614294,"about_ca_system_score_codex":0.001813004,"about_ca_system_score_gemma":0.0042611673,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W4406102421","doi":"10.1177/11795549241311408","title":"Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence","year":2025,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"Toronto Metropolitan University","keywords":"Prostate cancer; Medicine; Metastasis; Cancer; Radiation therapy; Clinical trial; Androgen deprivation therapy; Oncology; Disease; Internal medicine","score_opus":0.5304426451892652,"score_gpt":0.598056034547892,"score_spread":0.06761338935862682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406102421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097770644,0.9903509,0.0004168631,0.0009424672,0.0018148323,0.0044926987,0.000106296495,0.000035337318,0.0017428057],"genre_scores_gemma":[0.00006934245,0.9934593,0.0019291791,0.00017943376,0.0015184946,0.00075947354,0.00021601738,0.000054768887,0.0018140057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99355656,0.0013163486,0.0031107252,0.0010225822,0.00045148385,0.00054230774],"domain_scores_gemma":[0.99267316,0.004464285,0.0011873633,0.0006163805,0.00063003367,0.00042879226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005407787,0.00074031024,0.0073610214,0.0006937185,0.00011647976,0.000006480514,0.00023457517,0.0006264769,0.0004449479],"category_scores_gemma":[0.00077288493,0.00039013493,0.0008799271,0.0010285601,0.0020368514,0.000048704973,0.00011037451,0.0007535642,0.000023272145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009672155,0.0017222135,0.000011524715,0.00639686,0.002925314,0.000833711,0.0006900477,0.0000036178765,0.000003817345,0.0006791262,0.00024013378,0.98552644],"study_design_scores_gemma":[0.0026908836,0.028122889,0.0000048648617,0.03420451,0.018851923,0.000094307616,0.00059687695,0.00036761397,0.00012203245,0.0024725876,0.91202897,0.0004425439],"about_ca_topic_score_codex":0.0003185043,"about_ca_topic_score_gemma":0.00013431913,"teacher_disagreement_score":0.9850839,"about_ca_system_score_codex":0.0016702545,"about_ca_system_score_gemma":0.009516708,"threshold_uncertainty_score":0.99985504},"labels":[],"label_agreement":null}]}